Gene type may affect how cancer drug works in patients
Knowledge-focused
Completed
This early-phase study looked at how the cancer drug belinostat is processed in the body based on a person's UGT1A1 gene type. Seventeen adults with advanced solid tumors or blood cancers that had come back or stopped responding to treatment took part. The goal was to measure dru…
Phase: PHASE1 • Sponsor: Acrotech Biopharma Inc. • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC